landiolol has been researched along with Long QT Syndrome 1 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanoda, T; Kubo, K; Murao, K; Nakao, S; Shingu, K; Yamada, M | 1 |
1 other study(ies) available for landiolol and Long QT Syndrome 1
| Article | Year |
|---|---|
Successful management of cesarean section in a patient with Romano-Ward syndrome using landiolol, a selective and short-acting beta1 receptor antagonist.
Topics: Adrenergic beta-Antagonists; Adult; Cesarean Section; Electrocardiography; Female; Humans; Morpholines; Pregnancy; Pregnancy Complications, Cardiovascular; Romano-Ward Syndrome; Urea | 2005 |